
Dale R. Miller
Examiner (ID: 5360, Phone: (571)272-6146 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1673, 1693 |
| Total Applications | 838 |
| Issued Applications | 502 |
| Pending Applications | 84 |
| Abandoned Applications | 276 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12637512
[patent_doc_number] => 20180104334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => STORAGE BUFFER
[patent_app_type] => utility
[patent_app_number] => 15/573188
[patent_app_country] => US
[patent_app_date] => 2016-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4270
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15573188
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/573188 | STORAGE BUFFER | May 19, 2016 | Abandoned |
Array
(
[id] => 12790480
[patent_doc_number] => 20180155329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => ANHYDROUS CRYSTALLINE FORM OF (1S)-1,5-ANHYDRO-1-[3-[[5-(4-FLUOROPHENYL)-2-THIENYL]METHYL]-4-METHYLPHENYL]-D-GLUCITOL
[patent_app_type] => utility
[patent_app_number] => 15/574535
[patent_app_country] => US
[patent_app_date] => 2016-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7429
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15574535
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/574535 | ANHYDROUS CRYSTALLINE FORM OF (1S)-1,5-ANHYDRO-1-[3-[[5-(4-FLUOROPHENYL)-2-THIENYL]METHYL]-4-METHYLPHENYL]-D-GLUCITOL | May 17, 2016 | Abandoned |
Array
(
[id] => 11400373
[patent_doc_number] => 20170020911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-26
[patent_title] => 'ANTITHROMBIN-HEPARIN COMPOSITIONS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 15/130441
[patent_app_country] => US
[patent_app_date] => 2016-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12009
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15130441
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/130441 | ANTITHROMBIN-HEPARIN COMPOSITIONS AND METHODS | Apr 14, 2016 | Abandoned |
Array
(
[id] => 14482677
[patent_doc_number] => 10328097
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-25
[patent_title] => Glycosaminoglycan esters, processes for their preparation and their use in formulations for ophthalmic use
[patent_app_type] => utility
[patent_app_number] => 15/564994
[patent_app_country] => US
[patent_app_date] => 2016-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2239
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15564994
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/564994 | Glycosaminoglycan esters, processes for their preparation and their use in formulations for ophthalmic use | Apr 6, 2016 | Issued |
Array
(
[id] => 11471204
[patent_doc_number] => 20170057987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-02
[patent_title] => 'Trisaccharide Derivates, and Their Use as Adjuvants'
[patent_app_type] => utility
[patent_app_number] => 15/090853
[patent_app_country] => US
[patent_app_date] => 2016-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6279
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15090853
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/090853 | Trisaccharide Derivates, and Their Use as Adjuvants | Apr 4, 2016 | Abandoned |
Array
(
[id] => 16648700
[patent_doc_number] => 10925854
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-23
[patent_title] => Methods and compositions for preventing or treating fatty liver, protecting liver function or ameliorating liver diseases caused by fatty liver or other associated disorders
[patent_app_type] => utility
[patent_app_number] => 15/564507
[patent_app_country] => US
[patent_app_date] => 2016-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11613
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15564507
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/564507 | Methods and compositions for preventing or treating fatty liver, protecting liver function or ameliorating liver diseases caused by fatty liver or other associated disorders | Mar 30, 2016 | Issued |
Array
(
[id] => 16925179
[patent_doc_number] => 11046640
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-29
[patent_title] => Water-soluble L-DOPA esters
[patent_app_type] => utility
[patent_app_number] => 15/563003
[patent_app_country] => US
[patent_app_date] => 2016-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 34
[patent_no_of_words] => 12979
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15563003
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/563003 | Water-soluble L-DOPA esters | Mar 29, 2016 | Issued |
Array
(
[id] => 11962065
[patent_doc_number] => 20170266218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'NAD+ COENZYME FORMULATION AND METHODS OF MAKING AND USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/076462
[patent_app_country] => US
[patent_app_date] => 2016-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5985
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15076462
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/076462 | NAD+ COENZYME FORMULATION AND METHODS OF MAKING AND USING THE SAME | Mar 20, 2016 | Abandoned |
Array
(
[id] => 12641337
[patent_doc_number] => 20180105610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => Self-Supporting, Biodegradable Film Based on Hydrophobized Hyaluronic Acid, Method of Preparation and Use Thereof
[patent_app_type] => utility
[patent_app_number] => 15/556370
[patent_app_country] => US
[patent_app_date] => 2016-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10832
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15556370
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/556370 | Self-supporting, biodegradable film based on hydrophobized hyaluronic acid, method of preparation and use thereof | Mar 8, 2016 | Issued |
Array
(
[id] => 12150218
[patent_doc_number] => 20180021482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-25
[patent_title] => 'MEDICAL/COSMETIC MATERIAL AND ADHESION PREVENTING MATERIAL'
[patent_app_type] => utility
[patent_app_number] => 15/548004
[patent_app_country] => US
[patent_app_date] => 2016-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4585
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15548004
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/548004 | MEDICAL/COSMETIC MATERIAL AND ADHESION PREVENTING MATERIAL | Feb 24, 2016 | Abandoned |
Array
(
[id] => 16168180
[patent_doc_number] => 10709720
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-14
[patent_title] => Human milk oligosaccharides for modulating inflammation
[patent_app_type] => utility
[patent_app_number] => 15/019496
[patent_app_country] => US
[patent_app_date] => 2016-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 14
[patent_no_of_words] => 16668
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15019496
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/019496 | Human milk oligosaccharides for modulating inflammation | Feb 8, 2016 | Issued |
Array
(
[id] => 13805125
[patent_doc_number] => 10179824
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-15
[patent_title] => Method for producing hydrogels coupling high elastic modulus and absorbance
[patent_app_type] => utility
[patent_app_number] => 15/010626
[patent_app_country] => US
[patent_app_date] => 2016-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16886
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15010626
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/010626 | Method for producing hydrogels coupling high elastic modulus and absorbance | Jan 28, 2016 | Issued |
Array
(
[id] => 11706217
[patent_doc_number] => 20170174717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'METHOD OF SEPARATING BETANIN FROM RED QUINOA BY SUPERCRITICAL FLUID FRACTIONATION'
[patent_app_type] => utility
[patent_app_number] => 15/004099
[patent_app_country] => US
[patent_app_date] => 2016-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1227
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15004099
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/004099 | Method of separating betanin from red quinoa by supercritical fluid fractionation | Jan 21, 2016 | Issued |
Array
(
[id] => 13490087
[patent_doc_number] => 20180296586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => USE OF NADPH FOR PREPARATION OF A DRUG FOR ANTIPLATELET AGGREGATION
[patent_app_type] => utility
[patent_app_number] => 15/769063
[patent_app_country] => US
[patent_app_date] => 2016-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2799
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15769063
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/769063 | USE OF NADPH FOR PREPARATION OF A DRUG FOR ANTIPLATELET AGGREGATION | Jan 21, 2016 | Abandoned |
Array
(
[id] => 10769164
[patent_doc_number] => 20160115320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-28
[patent_title] => 'BIOMASS PRETREATMENT PROCESS'
[patent_app_type] => utility
[patent_app_number] => 14/987054
[patent_app_country] => US
[patent_app_date] => 2016-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14271
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14987054
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/987054 | BIOMASS PRETREATMENT PROCESS | Jan 3, 2016 | Abandoned |
Array
(
[id] => 10978388
[patent_doc_number] => 20160175331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'TREATMENT OF LEUKEMIA WITH ARTEMISININ DERIVATIVES AND COMBINATIONS WITH OTHER ANTINEOPLASTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/757433
[patent_app_country] => US
[patent_app_date] => 2015-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 14929
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14757433
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/757433 | Treatment of leukemia with artemisinin derivatives and combinations with other antineoplastic agents | Dec 22, 2015 | Issued |
Array
(
[id] => 11689567
[patent_doc_number] => 20170165282
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-15
[patent_title] => 'USE OF BETA-NICOTINAMIDE MONONUCLEOTIDE IN PREPARATION OF DRUGS FOR PREVENTING AND TREATING ARTERIOSCLEROSIS AND CARDIO-CEREBROVASCULAR DISEASES, AND DRUGS CONTAINING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/317848
[patent_app_country] => US
[patent_app_date] => 2015-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2544
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15317848
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/317848 | USE OF BETA-NICOTINAMIDE MONONUCLEOTIDE IN PREPARATION OF DRUGS FOR PREVENTING AND TREATING ARTERIOSCLEROSIS AND CARDIO-CEREBROVASCULAR DISEASES, AND DRUGS CONTAINING THE SAME | Dec 10, 2015 | Abandoned |
Array
(
[id] => 11689568
[patent_doc_number] => 20170165283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-15
[patent_title] => 'USE OF BETA-NICOTINAMIDE MONONUCLEOTIDE IN PREPARATION OF HEALTH-CARE PRODUCTS FOR PREVENTING AND TREATING ARTERIOSCLEROSIS AND CARDIO-CEREBROVASCULAR DISEASES, AND HEALTH-CARE PRODUCT CONTAINING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/317855
[patent_app_country] => US
[patent_app_date] => 2015-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2166
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15317855
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/317855 | USE OF BETA-NICOTINAMIDE MONONUCLEOTIDE IN PREPARATION OF HEALTH-CARE PRODUCTS FOR PREVENTING AND TREATING ARTERIOSCLEROSIS AND CARDIO-CEREBROVASCULAR DISEASES, AND HEALTH-CARE PRODUCT CONTAINING THE SAME | Dec 10, 2015 | Abandoned |
Array
(
[id] => 10820325
[patent_doc_number] => 20160166489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'GEL-BASED SUGAR SCRUB'
[patent_app_type] => utility
[patent_app_number] => 14/959310
[patent_app_country] => US
[patent_app_date] => 2015-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6999
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14959310
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/959310 | GEL-BASED SUGAR SCRUB | Dec 3, 2015 | Abandoned |
Array
(
[id] => 12029516
[patent_doc_number] => 20170319616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'A DIETARY FIBRE COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 15/529818
[patent_app_country] => US
[patent_app_date] => 2015-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8476
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15529818
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/529818 | Dietary fibre composition | Nov 25, 2015 | Issued |